Trial Profile
A Clinical Study of Supra-early Post-Surgery Chemotherapy Plus Standard TEMODAL Regimen Versus Standard TEMODAL Regimen in the Treatment on Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2021
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 09 Jul 2019 Planned number of patients changed from 100 to 180.
- 09 Jul 2019 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.
- 09 Jul 2019 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2020.